Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
N Engl J Med. 2021 Feb 25;384(8):705-716. doi: 10.1056/NEJMoa2024850.
N Engl J Med. 2021.
PMID: 33626253
Clinical Trial.